Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis | MicrobiomeTrials← Back to trialsNCT07800351
Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2027-02
Enrollment target: 46 participants Locations- Rheumatology, Rehabilitation and Physical Medicine department -Tanta university hospitals, Tanta, Gharbia Governorate, Egypt